Patent Grant
8980645
The present invention relates to a method for immobilizing Protein A on a self-assembled monolayer.
A biosensor is used to detect or quantify a target substance, namely an antigen, contained in a sample. A high affinity between an antigen and an antibody and a high affinity between Protein A and an antibody may be used in the biosensor. Specifically, Protein A is immobilized on the biosensor. Furthermore, an antibody is immobilized on the Protein A. When the antigen is supplied to the biosensor, the antigen is immobilized on the biosensor due to the high affinity between the antigen and the antibody.
Patent Document 1 discloses a prior biosensor utilizing the high affinity between Protein A and biotin.
According to the description regarding FIG. 7 of the Patent Document 1, the biosensor is used for screening an activity of a living molecule. The biosensor comprises a monolayer 7, an affinity tag 8, an adaptor molecule 9, and a protein 10. The monolayer 7 is composed of a self-assembled monolayer represented by chemical formula: X—R—Y (see Page 24 lines 23-26, Page 25 lines 3-20, Page 25 line 27-Page 26 line 13, and Page 26 lines 14-22 of Patent Document 1). Examples of X, R, and Y are HS—, an alkane, and a carboxyl group, respectively (see Page 25 lines 3-20, Page 25 line 27-Page 26 line 13, and Page 28 lines 21-23 of Patent Document 1).
In order to improve the detection sensitivity or the quantification accuracy of the target substance, it is required to increase an amount of Protein A to be immobilized on the biosensor.
The inventor of the present invention has discovered that the amount of immobilized Protein A per unit area was significantly increased by binding one molecule of the amino acid to a self-assembled monolayer and then immobilizing Protein A. The invention has been provided on the basis of the discovery.
The purpose of the present invention is to provide a method for increasing an amount of Protein A to be immobilized on the self-assembled monolayer, and a sensor with the protein A immobilized with the same method.
The following items A1 to C6 solve the above problem(s).
A1: A method for immobilizing a Protein A on a self-assembled monolayer, comprising the following step (a) and step (b) in this order:
(wherein R represents a side chain of one molecule of the amino acid)
(wherein R represents a side chain of one molecule of the amino acid)
A2: A method according to the A1, wherein the step (a) comprises the following step (a1) and step (a2) in this order:
A3: A method according to the A1, further comprising the following step (ab) between the step (a) and the step (b):
A4: A method according to the A2, further comprising the following step (a1a) between the step (a1) and the step (a2):
A5: A method according to the A1, wherein the chemical formula (II) is represented by the following chemical formula (III).
(wherein R represents a side chain of the one molecule of the amino acid)
A6: A method according to the A1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, threonine, proline, glutamate, and aspartate.
A7: A method according to the A1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, and threonine.
A8: A method according to the A1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, and tryptophan.
A9: A method according to the A1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, and glycine.
B1: A sensor comprising a self-assembled monolayer, a one molecule of the amino acid, and a Protein A, wherein,
(wherein R represents a side chain of one molecule of the amino acid)
B2: A method according to the B1, wherein the chemical formula (II) is represented by the following chemical formula (III).
(wherein R represents a side chain of one molecule of the amino acid)
B3: A sensor according to the B1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, threonine, proline, glutamate, and aspartate.
B4: A sensor according to the B1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, and threonine.
B5: A sensor according to the B1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, and tryptophan.
B6: A sensor according to the B1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, and glycine.
C1: A method for detecting or quantifying a target substance contained in a sample with a sensor, comprising the following steps (a) to (c) in this order,
(wherein R represents a side chain of one molecule of the amino acid)
C2: A method according to the C1, wherein the chemical formula (II) is represented by the following chemical formula (III).
(wherein R represents a side chain of one molecule of the amino acid)
C3: A method according to the C1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, threonine, proline, glutamate, and aspartate.
C4: A method according to the C1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, and threonine.
C5: A method according to the C1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, and tryptophan.
C6: A method according to the C1, wherein the one molecule of the amino acid is selected from the group consisting of cysteine, lysine, histidine, phenylalanine, and glycine.
The present invention achieves extreme increase of the amount of the protein A to be immobilized per unit area.
The embodiment of the present invention is described below with reference to
Preferably, a substrate 1 is a gold substrate. An example of the gold substrate is a substrate comprising gold on its surface. Specifically, the gold substrate may be a formed by sputtering gold on the surface of glass, plastic, or silicon dioxide (SiO2).
First, the substrate 1 is immersed into a solvent containing an alkanethiol. Preferably, the substrate is washed before the immersing. The alkanethiol has a carboxyl group at the end thereof. As the alkanethiol, a primary alkanethiol having carbon number within the range from 6 to 18 can be employed preferably. Thus, a self-assembled monolayer 2 is formed on the substrate 1.
A preferred concentration of the alkanethiol is approximately 1 to 10 mM. The solvent is not limited as long as it dissolves the alkanethiol. Examples of the preferred solvent are ethanol, DMSO (dimethyl sulfoxide), and dioxane. The preferred immersing period is approximately 12 to 48 hours.
Next, an amino acid 3 is supplied to the self-assembled monolayer 2. The carboxyl group (—COOH) which locates at the top end of the self-assembled monolayer 2 reacts with an amino group (—NH2) of the amino acid 3 to form a peptide bond represented by the following chemical formula (I).
(wherein R represents side chain of one molecule of the amino acid)
In the chemical formula (I), the one molecule of the amino acid 3 binds to the self-assembled monolayer 2.
The amino acid 3 is selected from nineteen kinds of amino acids consisting of cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, threonine, proline, glutamate, aspartate, and valine. Namely, in the chemical formula (I), R is the side chain of these nineteen kinds of amino acids.
when amino acid 3 is supplied to the self-assembled monolayer 2, equal to or more than two kinds of amino acids may be supplied simultaneously. Namely, when a solution containing the amino acid 3 is supplied to the self-assembled monolayer 2, the solution may contain equal to or more than two kind of the amino acids 3. In light of uniform bind of Protein A to the amino acid 3, which is described later, it is preferred that the solution contains a sole kind of amino acid.
As described later in the examples, arginine is not utilized as the amino acid 3. It is because an immobilization amount in case where arginine is supplied is lower than an immobilization amount in case where no amino acid is supplied. In case where no amino acid is supplied, a carboxyl group located at the end of the self-assembled monolayer 2 directly binds to Protein A.
Subsequently, Protein A 4 is supplied. The 5′-terminal amino group of the Protein A 4 reacts with the carboxyl group of the amino acid 3. The amino group of the lysine contained in the Protein A also reacts with the carboxyl group of the amino acid 3. Thus, two peptide bonds represented in following chemical formula (II) are formed to obtain a sensor.
(wherein R represents a side chain of one molecule of the amino acid)
One molecule of the Protein A 4 has only one 5′-terminal, whereas one molecule of the Protein A 4 has a lot of lysine group. Therefore, almost all of the chemical formula (II) is related particularly by the following chemical formula (III).
(wherein R represents a side chain of one molecule of the amino acid)
The obtained sensor is used for detecting or quantifying target substance contained in sample.
Specifically, an antibody which can bind the target substance specifically is supplied to the sensor to bind the antibody to the Protein A. Namely, the antibody is captured by the Protein A. Subsequently, the sample is supplied to the sensor to cause target substance, which is an antigen, contained in the sample to bind to the antibody. Needless to say, the antibody is bound specifically to the target substance.
Finally, with use of an ordinal analysis method such as Surface Plasmon Resonance (SPR) analysis method, the target substance is detected or quantified. Another analysis method such as Quarts Crystal Microbalance (QCM) may be used.
The following examples and a comparative example describe the present invention in more detail.
As shown in
(Preparation of a Sample Solution)
A sample solution of 16-Mercaptohexadecanoic acid with final concentration of 10 mM was prepared. The solvent thereof was ethanol.
(Formation of a Self-Assembled Monolayer)
A gold substrate (available from GE healthcare company, BR-1004-05) in which gold was vapor-deposited on glass was used as a substrate 1. The substrate 1 was washed for ten minutes with a piranha solution containing concentrated sulfuric acid and 30% hydrogen peroxide water. The volume ratio of the concentrated sulfuric acid to the 30% hydrogen peroxide water which are consisting of the piraniha solution was 3:1.
Subsequently, the gold substrate was immersed in the sample solution for 18 hours to form a self-assembled monolayer on the surface of the gold substrate. Finally, the substrate 1 was washed with pure water and dried.
(Immobilization of Protein A)
Protein A was bound to the carboxyl group located at the top end of the 16-Mercaptohexadecanoic acid which was forming the self-assembled monolayer to immobilize the Protein A.
Specifically, the carboxyl acid group located at the top end of the 16-Mercaptohexadecanoic acid was activated with use of 35 micro L of a mixture of 0.1M NHS (N-Hydroxysuccinimide) and 0.4M EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride). Subsequently, 35 micro L of Protein A (40 ug/ml) was added at the flow rate of 5 micro L/minute. Thus, the carboxyl group of the 16-Mercaptohexadecanoic acid was coupled with the amino group of the Protein A.
Experiment was conducted similarly to the comparative example except that glycine was supplied as the one molecule of the amino acid between the formation of self-assembled monolayer and the immobilization of the Protein A. The procedure and the results are described below.
(Immobilization of Amino Acid (Glycine))
Glycine was bound with the carboxyl group located at top end of the 16-Mercaptohexadecanoic acid which formed the self-assembled monolayer 2 to immobilize the glycine.
Specifically, after the carboxyl group had activated similar to the Comparative Example 1, 35 micro L of 0.1M glycine (pH: 8.9) was added at the flow rate of 5 micro L/minute. Thus, the carboxyl group of 16-Mercaptohexadecanoic acid was coupled with the amino group of the glycine.
(Immobilization of Protein A)
Subsequently, Protein A was bound to the carboxyl group of the glycine, to immobilize Protein A. Specifically, after the carboxyl group of the glycine was activated similar to the above, 35 micro L of Protein A (concentration: 250 micro gram/ml) was added at the flow rate of 5 micro L/minute. Thus, the carboxyl group was coupled with the 5′-terminal amino acid of the Protein A or the amino group of the lysine contained in the Protein A.
(Comparison of the Immobilization Amounts)
The immobilization amounts in the example 1 and in the comparative example 1 were measured with the use of an SPR device Biacore 3000 (available from GE healthcare company).
The term “immobilization amount” means the amount of the Protein A immobilized per unit area.
The ratio of the immobilization amount measured in the example 1 to that of measured in the comparative example 1 was approximately 8:1.
Threonine, methionine, isoleucine, proline, serine, glutamine, asparagine, phenylalanine, tryptophan, cysteine, histidine, alanine, lysine, leucine, glutamate, valine, aspartate, arginine, and tyrosine were supplied respectively instead of glycine. The respective immobilization amounts were measured similar to the example 1. These amino acids are twenty kinds of natural amino acid, provided that arginine is excluded. Table 1 shows the measured immobilization amounts.
Experiment was conducted similarly to the Example 1 except that arginine was supplied instead of glycine as one molecule of the amino acid, the immobilization amount was measured.
A skilled person would understand the following matters from the table 1. When the nineteen kinds of amino acids, except for arginine, was supplied, the immobilization amounts increase compared to comparative examples. Furthermore, the immobilization amount changes depending on amino acid.
Cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, threonine, proline, glutamate, and aspartate are preferred, because each measured immobilization amounts is equal to or more than twenty, in a case where one of these amino acids is supplied.
Cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, tryptophan, leucine, glutamine, alanine, isoleucine, and threonine are more preferred, because each measured immobilization amounts is equal to or more than fifty, in a case where one of these amino acids is supplied.
Cysteine, lysine, histidine, phenylalanine, tyrosine, glycine, asparagine, methionine, serine, and tryptophan are furthermore preferred, because each measured immobilization amounts is more than the average value (83.3%), in a case where one of these amino acids is supplied.
Cysteine, lysine, histidine, phenylalanine, and glycine are most preferred, because each measured immobilization amounts is equal to or more than one hundred, in a case where one of these amino acids is supplied.
The present invention achieves extreme increase of the amount of the Protein A to be immobilized per unit area. This allows the sensitivity or the accuracy of the biosensor to be improved. The biosensor may be used for an inspection or a diagnosis which requires the detection or the quantification of an antigen or an antibody contained in the living sample derived from a patient at a clinical practice.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2010-012710 | Jan 2010 | JP | national |
This application is a continuation of International Application No. PCT/JP2011/000268, filed on Jan. 19, 2011, which in turn claims the benefit of Japanese Application No. 2010-012710, filed on Jan. 25, 2010, the disclosures of which Applications are incorporated by reference herein.
| Number | Name | Date | Kind |
|---|---|---|---|
| 5137804 | Greene et al. | Aug 1992 | A |
| 5391478 | Greene et al. | Feb 1995 | A |
| 5969758 | Sauer et al. | Oct 1999 | A |
| 6037577 | Tanaka et al. | Mar 2000 | A |
| 6061093 | Yonemoto | May 2000 | A |
| 6115066 | Gowda et al. | Sep 2000 | A |
| 6235535 | Keinanen et al. | May 2001 | B1 |
| 6344877 | Gowda et al. | Feb 2002 | B1 |
| 6366321 | Yonemoto | Apr 2002 | B1 |
| 6406921 | Wagner et al. | Jun 2002 | B1 |
| 6475808 | Wagner et al. | Nov 2002 | B1 |
| 6576478 | Wagner et al. | Jun 2003 | B1 |
| 6582969 | Wagner et al. | Jun 2003 | B1 |
| 6596545 | Wagner et al. | Jul 2003 | B1 |
| 6650369 | Koizumi et al. | Nov 2003 | B2 |
| 6682942 | Wagner et al. | Jan 2004 | B1 |
| 6791613 | Shinohara et al. | Sep 2004 | B2 |
| 7030922 | Sakuragi | Apr 2006 | B2 |
| 7110030 | Kochi et al. | Sep 2006 | B1 |
| 7116365 | Ueno et al. | Oct 2006 | B1 |
| 7277130 | Korthout et al. | Oct 2007 | B2 |
| 7283168 | Watanabe | Oct 2007 | B2 |
| 7317483 | Tanimoto | Jan 2008 | B2 |
| 7375753 | Mabuchi | May 2008 | B2 |
| 7714920 | Inagaki et al. | May 2010 | B2 |
| 20020110932 | Wagner et al. | Aug 2002 | A1 |
| 20020115225 | Wagner et al. | Aug 2002 | A1 |
| 20030137594 | Koizumi et al. | Jul 2003 | A1 |
| 20030138973 | Wagner et al. | Jul 2003 | A1 |
| 20040027471 | Koseki et al. | Feb 2004 | A1 |
| 20040175300 | Indermuhle et al. | Sep 2004 | A1 |
| 20040197931 | Indermuhle et al. | Oct 2004 | A1 |
| 20040251396 | Koyama | Dec 2004 | A1 |
| 20050083408 | Mabuchi | Apr 2005 | A1 |
| 20050128326 | Korthout et al. | Jun 2005 | A1 |
| 20050281816 | Lamping et al. | Dec 2005 | A1 |
| 20060001751 | Abe et al. | Jan 2006 | A1 |
| 20090011952 | Gau | Jan 2009 | A1 |
| 20090042744 | Wagner et al. | Feb 2009 | A1 |
| 20090047685 | Kohno et al. | Feb 2009 | A1 |
| 20090047695 | Wagner et al. | Feb 2009 | A1 |
| 20090202580 | Uggeri et al. | Aug 2009 | A1 |
| 20090325262 | Hodneland et al. | Dec 2009 | A1 |
| 20100113476 | Chen et al. | May 2010 | A1 |
| 20100233827 | Kusaki et al. | Sep 2010 | A1 |
| 20120238036 | Hataoka | Sep 2012 | A1 |
| 20130029364 | Hataoka | Jan 2013 | A1 |
| Number | Date | Country |
|---|---|---|
| 0 865 197 | Sep 1998 | EP |
| 908957 | Apr 1999 | EP |
| 2 347 212 | Aug 2000 | GB |
| 01-209370 | Aug 1989 | JP |
| 07-113637 | Dec 1995 | JP |
| 9-247537 | Sep 1997 | JP |
| 10-93066 | Apr 1998 | JP |
| 11-014627 | Jan 1999 | JP |
| 11-112018 | Apr 1999 | JP |
| 2000-515965 | Nov 2000 | JP |
| 2001-045375 | Feb 2001 | JP |
| 2001-305139 | Oct 2001 | JP |
| 2002-511215 | Apr 2002 | JP |
| 2002-520618 | Jul 2002 | JP |
| 2002-520618 | Jul 2002 | JP |
| 2002-520621 | Jul 2002 | JP |
| 2002-237584 | Aug 2002 | JP |
| 2003-230055 | Aug 2003 | JP |
| 2005-509737 | Apr 2005 | JP |
| 2006-502719 | Jan 2006 | JP |
| 2006-166837 | Jun 2006 | JP |
| 2006-208012 | Aug 2006 | JP |
| 2006-266707 | Oct 2006 | JP |
| 2006-266707 | Oct 2006 | JP |
| 2007-528850 | Oct 2007 | JP |
| 2007-298334 | Nov 2007 | JP |
| 2009-222401 | Oct 2009 | JP |
| 2009-541259 | Nov 2009 | JP |
| 2010-117140 | May 2010 | JP |
| 2010-237191 | Oct 2010 | JP |
| 2010-532475 | Oct 2010 | JP |
| 8911100 | Nov 1989 | WO |
| 9800714 | Jan 1998 | WO |
| 9856170 | Dec 1998 | WO |
| 0004382 | Jan 2000 | WO |
| 0004390 | Jan 2000 | WO |
| WO 0004382 | Jan 2000 | WO |
| 03018854 | Mar 2003 | WO |
| 03069897 | Aug 2003 | WO |
| 2005018413 | Mar 2005 | WO |
| 2007063616 | Jun 2007 | WO |
| 2009005567 | Jan 2009 | WO |
| 2011089903 | Jul 2011 | WO |
| 2012029202 | Mar 2012 | WO |
| 2012053138 | Apr 2012 | WO |
| 2012168988 | Dec 2012 | WO |
| 2013005269 | Jan 2013 | WO |
| Entry |
|---|
| International Search Report issued in International Patent Application No. PCT/JP2011/000268, mailed Apr. 5, 2011. |
| Gooding et al., “Amperometric biosensor with enzyme amplification fabricated using self-assembled monolayers of alkanethiols: the influence of the spatial distribution of the enzymes”, Electrochemistry Communications, vol. 2, No. 4, Apr. 1, 2000 , pp. 217-221. |
| International Search Report issued in International Application No. PCT/JP2011/004127 issued on Aug. 16, 2011. |
| International Search Report mailed Mar. 29, 2011 issued in corresponding International Application No. PCT/JP2011/001185. |
| International Search Report issued in International Patent Application No. PCT/JP2011/007239 dated Feb. 7, 2012. |
| International Search Report issued in International Application No. PCT/JP2011/007238 with Date of mailing Feb. 7, 2012. |
| Besselink et al., “N-hydroxysuccinimide-activated glycine-sepharose,” Applied Biochemistry and Biotechnology 2003, vol. 43, pp. 227-246. |
| Diamandis et al., “The biotin-(strept)avidin system: principles and applications in biotechnology,” Clin. Chem. 1991, vol. 37, No. 5, pp. 625-636. |
| Non-Final Office Action issued in U.S. Appl. No. 13/629,121 dated Jan. 4, 2013. |
| Non-Final Office Action issued in U.S. Appl. No. 13/629,121 dated Mar. 5, 2013. |
| Non-Final Office Action issued in U.S. Appl. No. 13/629,121 dated Sep. 16, 2013. |
| International Search Report issued in International Application No. PCT/JP2011/005037 with Date of mailing Oct. 11, 2011, with English Translation. |
| Kondo et al., “Plasma-Assisted Immobilization of Heparin onto Low-Density Polyethylene Surface,” Chem. Pharm. Bull., 2008, vol. 56, No. 7, p. 921-925. |
| Shriver-Lake et al., Antibody Immobilization Using Heterobifunctional Crosslinkers, Biosensors & Bioelectronics, 1997, vol. 12, No. 11, p. 1101-1106. |
| English translation of Chinese Search Report issued in Chinese Application No. 201180037848.6 dated Mar. 3, 2014. |
| Number | Date | Country | |
|---|---|---|---|
| 20120238036 A1 | Sep 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/JP2011/000268 | Jan 2011 | US |
| Child | 13483840 | US |
